Globally, breast cancer is the second-most common cause of cancer-related deaths among women. Recent research suggests that the gut microbiome may influence the development of breast cancer via hormonal, immunological, and metabolically mediated pathways. This review systematically summarizes the literature on the differences in gut microbiome diversity between women with breast cancer and without breast cancer. Women with breast cancer show consistently lower alpha diversity than women without breast cancer, particularly in postmenopausal women and those with metabolic dysfunction. These patterns suggest that gut microbiome diversity serves as an ecosystem-level indicator that interacts with the host context rather than acting as a standalone biomarker risk. This review also identifies the limitations in the current literature and the limitations of this review. For example, the evidence presented here is based on cross-sectional observational studies, and the methods for analyzing gut microbiota are highly heterogeneous. This review is non-systematic, focusing solely on gut microbiota diversity rather than functional/multi-site datasets. The insights presented in this review underscore the need for large, longitudinal studies of ethnically diverse cohorts and standardized methods to assess gut microbiota diversity, with the goal of determining how modifying gut microbiota diversity could provide a basis for developing personalized prevention/management strategies for breast cancer.
Research Article
Open Access